GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » Debt-to-Asset

Applied DNA Sciences (FRA:UDJ) Debt-to-Asset : 0.11 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Debt-to-Asset?

Applied DNA Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.48 Mil. Applied DNA Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.43 Mil. Applied DNA Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €8.44 Mil. Applied DNA Sciences's debt to asset for the quarter that ended in Mar. 2024 was 0.11.


Applied DNA Sciences Debt-to-Asset Historical Data

The historical data trend for Applied DNA Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Debt-to-Asset Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.21 - - 0.09

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 0.09 0.11 0.11

Competitive Comparison of Applied DNA Sciences's Debt-to-Asset

For the Diagnostics & Research subindustry, Applied DNA Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Debt-to-Asset falls into.



Applied DNA Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Applied DNA Sciences's Debt-to-Asset for the fiscal year that ended in Sep. 2023 is calculated as

Applied DNA Sciences's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences  (FRA:UDJ) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Applied DNA Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (FRA:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines